These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 8581064)

  • 21. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC; Denekamp J; Minchinton AI
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide increases cellular glutathione levels in rat lung fibroblasts.
    White AC; Maloney EK; Boustani MR; Hassoun PM; Fanburg BL
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):442-8. PubMed ID: 7546774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.
    Gallo JM; Brennan J; Hamilton TC; Halbherr T; Laub PB; Ozols RF; O'Dwyer PJ
    Cancer Res; 1995 Oct; 55(20):4507-11. PubMed ID: 7553617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
    Kang YJ; Emery D; Enger MD
    Cell Biol Toxicol; 1991 Jul; 7(3):249-61. PubMed ID: 1933516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of glutathione level in cultured human melanoma cells.
    Karg E; Brötell H; Rosengren E; Rorsman H
    Acta Derm Venereol; 1989; 69(2):137-41. PubMed ID: 2564231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
    Dierickx PJ
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
    Miranda AF; Wiley MJ; Wells PG
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth-associated modifications of low-molecular-weight thiols and protein sulfhydryls in human bronchial fibroblasts.
    Atzori L; Dypbukt JM; Sundqvist K; Cotgreave I; Edman CC; Moldéus P; Grafström RC
    J Cell Physiol; 1990 Apr; 143(1):165-71. PubMed ID: 2318904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L; Mimnaugh EG; Myers CE; Sinha BK
    Cancer Res; 1989 Feb; 49(3):511-5. PubMed ID: 2535960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Jin YZ; Ding L; Shen ZF; Cai RM; Xu LM; Yang JK; Jin XQ; Lu WQ; Xu JF
    Chin Med J (Engl); 1992 Aug; 105(8):647-50. PubMed ID: 1458967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP; Epp ER; Biaglow JE; Morse-Gaudio M; Zachgo E
    Radiat Res; 1984 May; 98(2):370-80. PubMed ID: 6539482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.